a developer of novel treatments for diseases related to the human microbiome
Industry Biotechnology
A.I.dvisor indicates that over the last year, MCRB has been loosely correlated with RIGL. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if MCRB jumps, then RIGL could also see price increases.
Ticker / NAME | Correlation To MCRB | 1D Price Change % | ||
---|---|---|---|---|
MCRB | 100% | -11.10% | ||
RIGL - MCRB | 38% Loosely correlated | +0.70% | ||
ATNM - MCRB | 37% Loosely correlated | -5.00% | ||
OTLK - MCRB | 32% Poorly correlated | -4.94% | ||
ARCT - MCRB | 30% Poorly correlated | -2.04% | ||
RCKT - MCRB | 30% Poorly correlated | -2.25% | ||
More |
Ticker / NAME | Correlation To MCRB | 1D Price Change % |
---|---|---|
MCRB | 100% | -11.10% |
drugs theme (254 stocks) | 25% Poorly correlated | -1.72% |
novel medical theme (11 stocks) | 18% Poorly correlated | +0.29% |
biotechnology theme (238 stocks) | 13% Poorly correlated | -1.80% |
human theme (15 stocks) | 12% Poorly correlated | +1.86% |